CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-20 | Landis John B. Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-20 | DICICCO WENDY F Director | Grant or award · Stock Option (Right to Buy) | +26,100 | 26,100 | ||
| 2023-06-20 | DICICCO WENDY F Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-20 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +27,100 | 27,100 | ||
| 2023-06-20 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2023-06-20 | ADAMIS ANTHONY P Director | Grant or award · Stock Option (Right to Buy) | +26,100 | 26,100 | ||
| 2023-06-20 | ADAMIS ANTHONY P Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-20 | Zaderej Karen L. Director | Grant or award · Stock Option (Right to Buy) | +26,100 | 26,100 | ||
| 2023-06-20 | Zaderej Karen L. Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-20 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Grant or award · Restricted Stock Units | +45,855 | 45,855 | ||
| 2023-06-20 | Jones David Scott SVP & Chief Commercial Officer | Grant or award · Restricted Stock Units | +45,855 | 45,855 | ||
| 2023-06-20 | Paggiarino Dario A. Chief Medical Officer | Grant or award · Restricted Stock Units | +45,855 | 45,855 | ||
| 2023-06-20 | Elston George Chief Financial Officer | Grant or award · Restricted Stock Units | +45,855 | 45,855 | ||
| 2023-06-20 | Lurker Nancy CEO | Grant or award · Restricted Stock Units | +225,400 | 225,400 | ||
| 2023-06-20 | Duker Jay S. President and COO | Grant or award · Restricted Stock Units | +62,380 | 62,380 | ||
| 2023-05-30 | Liu Ye Director | Sale | −1 | $6.00 | $6 | 3,010,721 |
| 2023-05-25 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-25 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Grant or award · Restricted Stock Units | +7,500 | 7,500 | ||
| 2023-05-25 | Elston George Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-05-25 | Elston George Chief Financial Officer | Grant or award · Restricted Stock Units | +22,500 | 22,500 |
Page 23 of 31 · 616 trades